{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T11:06:05Z","timestamp":1768561565065,"version":"3.49.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,5,9]],"date-time":"2017-05-09T00:00:00Z","timestamp":1494288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,5,9]],"date-time":"2017-05-09T00:00:00Z","timestamp":1494288000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Chemokines play an important role in the pathophysiology of dermatomyositis (DM) with interstitial pneumonia (IP). However, the relation between chemokines and the disease activity or prognosis of DM-IP has not been elucidated. We evaluated the serum C-C motif chemokine ligand (CCL) 2, Th1 chemokines (C-X-C motif chemokine ligand [CXCL] 9, CXCL10, CXCL11), and Th2 chemokine (CCL17) profiles of 30 patients, and examined the relation between these chemokines and the disease activity or prognosis of DM-IP. Initial serum CCL2 level was higher in the death group (<jats:italic>P<\/jats:italic>\u2009=\u20090.007). To determine the cut-off points effective as poor prognostic factors of DM-IP, ROC curve analysis was carried out on initial serum CCL2 level. The value that maximized the area under the ROC curve was 894\u2009pg\/mL (sensitivity: 100%, specificity: 70.8%). Serum CCL2, CXCL9, CXCL10, and CXCL11 levels were lower at 2 weeks after treatment initiation than before treatment. Serum CCL2, CXCL10, and CXCL11 levels at 2 weeks after treatment initiation were higher in the death group. Serum levels of chemokines such as CCL2, CXCL10, and CXCL11 may be possible biomarkers of disease activity and prognosis in DM-IP, and serum CCL2 level may be useful when deciding initial treatment.<\/jats:p>","DOI":"10.1038\/s41598-017-01685-5","type":"journal-article","created":{"date-parts":[[2017,5,3]],"date-time":"2017-05-03T13:43:37Z","timestamp":1493819017000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Chemokine profiles of interstitial pneumonia in patients with dermatomyositis: a case control study"],"prefix":"10.1038","volume":"7","author":[{"given":"Katsuhiro","family":"Oda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuya","family":"Kotani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tohru","family":"Takeuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takaaki","family":"Ishida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Shoda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kentaro","family":"Isoda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuzo","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuichiro","family":"Nishimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeki","family":"Makino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,5,9]]},"reference":[{"key":"1685_CR1","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1056\/NEJM197502132920706","volume":"292","author":"A Bohan","year":"1975","unstructured":"Bohan, A. & Peter, J. B. Polymyositis and dermatomyositis (first of two parts). N Engl J Med. \n                           292, 344\u2013347, doi:10.1056\/NEJM197502132920706 (1975).","journal-title":"N Engl J Med."},{"key":"1685_CR2","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1056\/NEJM197502202920807","volume":"292","author":"A Bohan","year":"1975","unstructured":"Bohan, A. & Peter, J. B. Polymyositis and dermatomyositis (second of two parts). N Engl J Med. \n                           292, 403\u2013407, doi:10.1056\/NEJM197502202920807 (1975).","journal-title":"N Engl J Med."},{"key":"1685_CR3","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/S0733-8635(02)00021-9","volume":"20","author":"RD Sontheimer","year":"2002","unstructured":"Sontheimer, R. D. Dermatomyositis: an overview of recent progress with emphasis on dermatologic aspects. Dermatol Clin. \n                           20, 387\u2013408, doi:10.1016\/S0733-8635(02)00021-9 (2002).","journal-title":"Dermatol Clin."},{"key":"1685_CR4","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.jaad.2005.10.041","volume":"54","author":"P Gerami","year":"2006","unstructured":"Gerami, P., Schope, J. M., McDonald, L., Walling, H. W. & Sontheimer, R. D. A systematic review of adult-onset clinically amyopathic dermatomyositis (dermatomyositis sin\u00e9 myositis): a missing link within the spectrum of the idiopathic inflammatory myopathies. J Am Acad Dermatol. \n                           54, 597\u2013613, doi:10.1016\/j.jaad.2005.10.041 (2006).","journal-title":"J Am Acad Dermatol."},{"key":"1685_CR5","first-page":"263","volume":"14","author":"YM Maugars","year":"1996","unstructured":"Maugars, Y. M. et al. Long-term prognosis of 69 patients with dermatomyositis or polymyositis. Clin Exp Rheumatol. \n                           14, 263\u2013274 (1996).","journal-title":"Clin Exp Rheumatol."},{"key":"1685_CR6","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1002\/art.1780280303","volume":"28","author":"J Benbassat","year":"1985","unstructured":"Benbassat, J. et al. Prognostic factors in polymyositis\/dermatomyositis. A computer-assisted analysis of ninety-two cases. Arthritis Rheum. \n                           28, 249\u2013255, doi:10.1002\/(ISSN)1529-0131 (1985).","journal-title":"Arthritis Rheum."},{"key":"1685_CR7","doi-asserted-by":"publisher","first-page":"231","DOI":"10.3109\/s10165-003-0205-1","volume":"13","author":"K Nagasaka","year":"2003","unstructured":"Nagasaka, K. et al. Efficacy of combination treatment with cyclosporine A and corticosteroids for acute interstitial pneumonitis associated with dermatomyositis. Mod Rheumatol. \n                           13, 231\u2013238, doi:10.3109\/s10165-003-0205-1 (2003).","journal-title":"Mod Rheumatol."},{"key":"1685_CR8","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1007\/s10067-011-1713-6","volume":"30","author":"T Kotani","year":"2011","unstructured":"Kotani, T. et al. Combination with corticosteroids and cyclosporine-A improves pulmonary function test results and chest HRCT findings in dermatomyositis patients with acute\/subacute interstitial pneumonia. Clin Rheumatol. \n                           30, 1021\u20131028, doi:10.1007\/s10067-011-1713-6 (2011).","journal-title":"Clin Rheumatol."},{"key":"1685_CR9","first-page":"128","volume":"12","author":"S Miyake","year":"2002","unstructured":"Miyake, S. et al. Usefulness of cyclosporine A on rapidly progressive interstitial pneumonia in dermatomyositis. Sarcoidosis Vasc Diffuse Lung Dis. \n                           19, 128\u2013133 (2002).","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis."},{"key":"1685_CR10","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1007\/s10067-009-1358-x","volume":"29","author":"M Ando","year":"2010","unstructured":"Ando, M. et al. Successful treatment with tacrolimus of progressive interstitial pneumonia associated with amyopathic dermatomyositis refractory to cyclosporine. Clin Rheumatol. \n                           29, 443\u2013445, doi:10.1007\/s10067-009-1358-x (2010).","journal-title":"Clin Rheumatol."},{"key":"1685_CR11","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1093\/rheumatology\/kel112","volume":"46","author":"Y Yamasaki","year":"2007","unstructured":"Yamasaki, Y. et al. Intravenous cyclophosphamide therapy for progressive interstitial pneumonia in patients with polymyositis\/dermatomyositis. Rheumatology (Oxford). \n                           46, 124\u2013130, doi:10.1093\/rheumatology\/kel112 (2007).","journal-title":"Rheumatology (Oxford)."},{"key":"1685_CR12","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s11926-005-0061-4","volume":"7","author":"A Schnabel","year":"2005","unstructured":"Schnabel, A., Hellmich, B. & Gross, W. L. Interstitial lung disease in polymyositis and dermatomyositis. Curr Rheumatol Rep. \n                           7, 99\u2013105, doi:10.1007\/s11926-005-0061-4 (2005).","journal-title":"Curr Rheumatol Rep."},{"key":"1685_CR13","first-page":"1719","volume":"32","author":"H Kameda","year":"2005","unstructured":"Kameda, H. et al. Combination therapy with corticosteroids, cyclosporine A, and intravenous pulse cyclophosphamide for acute\/subacute interstitial pneumonia in patients with dermatomyositis. J Rheumatol. \n                           32, 1719\u20131726 (2005).","journal-title":"J Rheumatol."},{"key":"1685_CR14","first-page":"91","volume":"21","author":"H Hoaumi","year":"2016","unstructured":"Hozumi, H. et al. Comprehensive assessment of myositis-specific autoantibodies in polymyositis\/dermatomyositis-associated interstitial lung disease. Respir Med.\u00a0121, 91\u201399 (2016).","journal-title":"Respir Med."},{"key":"1685_CR15","doi-asserted-by":"publisher","first-page":"361","DOI":"10.2169\/internalmedicine.49.2889","volume":"49","author":"Y Koreeda","year":"2010","unstructured":"Koreeda, Y. et al. Clinical and Pathological Findings of Interstitial Lung Disease Patients with Anti-Aminoacyl-tRNA Synthetase Autoantibodies. Inter Med. \n                           49, 361\u2013369, doi:10.2169\/internalmedicine.49.2889 (2010).","journal-title":"Inter Med."},{"key":"1685_CR16","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1002\/art.21023","volume":"52","author":"S Sato","year":"2005","unstructured":"Sato, S. et al. Autoantibodies to a 140-kd polypeptide, CADM-140, in Japanese patients with clinically amyopathic dermatomyositis. Arthritis Rheum. \n                           52, 1571\u20131576, doi:10.1002\/(ISSN)1529-0131 (2005).","journal-title":"Arthritis Rheum."},{"key":"1685_CR17","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1093\/rheumatology\/keq149","volume":"49","author":"T Gono","year":"2010","unstructured":"Gono, T. et al. Clinical manifestation and prognostic factor in anti-melanoma differentiation-associated gene 5 antibody-associated interstitial lung disease as a complication of dermatomyositis. Rheumatology (Oxford). \n                           49, 1713\u20131719, doi:10.1093\/rheumatology\/keq149 (2010).","journal-title":"Rheumatology (Oxford)."},{"key":"1685_CR18","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1093\/rheumatology\/keq073","volume":"49","author":"T Gono","year":"2010","unstructured":"Gono, T. et al. Increased ferritin predicts development and severity of acute interstitial lung disease as a complication of dermatomyositis. Rheumatology (Oxford). \n                           49, 1354\u20131360, doi:10.1093\/rheumatology\/keq073 (2010).","journal-title":"Rheumatology (Oxford)."},{"key":"1685_CR19","doi-asserted-by":"publisher","first-page":"223","DOI":"10.3109\/s10165-010-0371-x","volume":"21","author":"T Gono","year":"2011","unstructured":"Gono, T. et al. Serum ferritin correlates with activity of anti-MDA5 antibody-associated acute interstitial lung disease as a complication of dermatomyositis. Mod Rheumatol. \n                           21, 223\u2013227, doi:10.3109\/s10165-010-0371-x (2011).","journal-title":"Mod Rheumatol."},{"key":"1685_CR20","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1093\/rheumatology\/kes102","volume":"51","author":"T Gono","year":"2012","unstructured":"Gono, T. et al. Anti-MDA5 antibody, ferritin and IL-18 are useful for the evaluation of response to treatment in interstitial lung disease with anti-MDA5 antibody-positive dermatomyositis. Rheumatology (Oxford). \n                           51, 1563\u20131570, doi:10.1093\/rheumatology\/kes102 (2012).","journal-title":"Rheumatology (Oxford)."},{"key":"1685_CR21","doi-asserted-by":"publisher","first-page":"e89610","DOI":"10.1371\/journal.pone.0089610","volume":"9","author":"K Isoda","year":"2014","unstructured":"Isoda, K. et al. Pre-treatment ferritin level and alveolar-arterial oxygen gradient can predict mortality rate due to acute\/subacute interstitial pneumonia in dermatomyositis treated by cyclosporine a\/glucocorticosteroid combination therapy: a case control study [corrected]. PLoS One. \n                           9, e89610, doi:10.1371\/journal.pone.0089610 (2014).","journal-title":"PLoS One."},{"key":"1685_CR22","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1093\/rheumatology\/keh723","volume":"44","author":"EH Kang","year":"2005","unstructured":"Kang, E. H. et al. Interstitial lung disease in patients with polymyositis, dermatomyositis and amyopathic dermatomyositis. Rheumatology (Oxford). \n                           44, 1282\u20131286, doi:10.1093\/rheumatology\/keh723 (2005).","journal-title":"Rheumatology (Oxford)."},{"key":"1685_CR23","doi-asserted-by":"publisher","first-page":"43","DOI":"10.4137\/CMAMD.S9398","volume":"5","author":"Y Shimojima","year":"2012","unstructured":"Shimojima, Y. et al. Coadministration of cyclosporin a with prednisolone in acute interstitial pneumonia complicating polymyositis\/dermatomyositis. Clin Med Insights Arthritis Musculoskelet Disord. \n                           5, 43\u201352, doi:10.4137\/CMAMD.S9398 (2012).","journal-title":"Clin Med Insights Arthritis Musculoskelet Disord."},{"key":"1685_CR24","doi-asserted-by":"publisher","first-page":"738","DOI":"10.3109\/14397595.2015.1134392","volume":"26","author":"T Kotani","year":"2016","unstructured":"Kotani, T. et al. Initial limited three-level thin-section computed tomography scorings predict the prognosis of acute\/subacute interstitial pneumonia in patients with dermatomyositis. Mod Rheumatol. \n                           26, 738\u2013743, doi:10.3109\/14397595.2015.1134392 (2016).","journal-title":"Mod Rheumatol."},{"key":"1685_CR25","doi-asserted-by":"publisher","first-page":"872","DOI":"10.3109\/s10165-012-0756-0","volume":"23","author":"S Arai","year":"2013","unstructured":"Arai, S. et al. Marked increase in serum KL-6 and surfactant protein D levels during the first 4 weeks after treatment predicts poor prognosis in patients with active interstitial pneumonia associated with polymyositis\/dermatomyositis. Mod Rheumatol. \n                           23, 872\u2013883, doi:10.3109\/s10165-012-0756-0 (2013).","journal-title":"Mod Rheumatol."},{"key":"1685_CR26","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1111\/j.1365-2133.2012.11145.x","volume":"167","author":"WC Sun","year":"2012","unstructured":"Sun, W. C., Sun, Y. C., Lin, H., Yan, B. & Shi, G. X. Dysregulation of the type I interferon system in adult-onset clinically amyopathic dermatomyositis has a potential contribution to the development of interstitial lung disease. Br J Dermatol. \n                           167, 1236\u20131244, doi:10.1111\/j.1365-2133.2012.11145.x (2012).","journal-title":"Br J Dermatol."},{"key":"1685_CR27","doi-asserted-by":"publisher","first-page":"85","DOI":"10.3109\/14397595.2014.900843","volume":"25","author":"Y Horai","year":"2015","unstructured":"Horai, Y. et al. Serum interferon-\u03b1 is a useful biomarker in patients with anti-melanoma differentiation-associated gene 5 (MDA5) antibody-positive dermatomyositis. Mod Rheumatol. \n                           25, 85\u201389, doi:10.3109\/14397595.2014.900843 (2015).","journal-title":"Mod Rheumatol."},{"key":"1685_CR28","doi-asserted-by":"publisher","first-page":"2196","DOI":"10.1093\/rheumatology\/keu258","volume":"53","author":"T Gono","year":"2014","unstructured":"Gono, T. et al. Cytokine profiles in polymyositis and dermatomyositis complicated by rapidly progressive or chronic interstitial lung disease. Rheumatology (Oxford). \n                           53, 2196\u20132203, doi:10.1093\/rheumatology\/keu258 (2014).","journal-title":"Rheumatology (Oxford)."},{"key":"1685_CR29","doi-asserted-by":"publisher","first-page":"633","DOI":"10.3109\/14397595.2013.844390","volume":"24","author":"M Nara","year":"2014","unstructured":"Nara, M. et al. Serum interleukin 6 levels as a useful prognostic predictor of clinically amyopathic dermatomyositis with rapidly progressive interstitial lung disease. Mod Rheumatol. \n                           24, 633\u2013636, doi:10.3109\/14397595.2013.844390 (2014).","journal-title":"Mod Rheumatol."},{"key":"1685_CR30","doi-asserted-by":"crossref","unstructured":"Kawasumi, H. et al. IL-6, IL-8, and IL-10 are associated with hyperferritinemia in rapidly progressive interstitial lung disease with polymyositis\/dermatomyositis. Biomed Res Int. 2014, 815245 (2014).","DOI":"10.1155\/2014\/815245"},{"key":"1685_CR31","doi-asserted-by":"publisher","first-page":"1878","DOI":"10.1093\/rheumatology\/keq196","volume":"49","author":"T Gono","year":"2010","unstructured":"Gono, T. et al. Interleukin-18 is a key mediator in dermatomyositis: potential contribution to development of interstitial lung disease. Rheumatology (Oxford). \n                           49, 1878\u20131881, doi:10.1093\/rheumatology\/keq196 (2010).","journal-title":"Rheumatology (Oxford)."},{"key":"1685_CR32","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1007\/s10067-012-2142-x","volume":"32","author":"Y Muro","year":"2013","unstructured":"Muro, Y., Sugiura, K. & Akiyama, M. Limitations of a single-point evaluation of anti-MDA5 antibody, ferritin, and IL-18 in predicting the prognosis of interstitial lung disease with anti-MDA5 antibody-positive dermatomyositis. Clin Rheumatol. \n                           32, 395\u2013398, doi:10.1007\/s10067-012-2142-x (2013).","journal-title":"Clin Rheumatol."},{"key":"1685_CR33","unstructured":"Chen, F., Shu, X. M., Wang, D. X., Wang, G. C. & Lu, X. Measurement and clinical significance of serum monocyte chemoattractant protein-1 in patients with polymyosits\/dermatomyosits. Beijing Da Xue Bao. 44, 204\u2013208 (2012)."},{"key":"1685_CR34","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.jdermsci.2010.07.012","volume":"60","author":"T Kawashima","year":"2010","unstructured":"Kawashima, T. et al. Serum TARC\/CCL17 levels are increased in dermatomyositis associated with interstitial lung disease. J Dermatol Sci. \n                           60, 52\u201354, doi:10.1016\/j.jdermsci.2010.07.012 (2010).","journal-title":"J Dermatol Sci."},{"key":"1685_CR35","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1164\/ajrccm.161.2.ats3-00","volume":"161","author":"American Thoracic Society","year":"2000","unstructured":"American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS). Am J Respir Crit Care Med. \n                           161, 646\u2013664, doi:10.1164\/ajrccm.161.2.ats3-00 (2000).","journal-title":"Am J Respir Crit Care Med."},{"key":"1685_CR36","doi-asserted-by":"publisher","first-page":"3909","DOI":"10.1007\/s00296-011-2323-y","volume":"32","author":"F Chen","year":"2012","unstructured":"Chen, F., Wang, D., Shu, X., Nakashima, R. & Wang, G. Anti-MDA5 antibody is associated with A\/SIP and decreased T cells in peripheral blood and predicts poor prognosis of ILD in Chinese patients with dermatomyositis. Rheumatol Int. \n                           32, 3909\u20133915, doi:10.1007\/s00296-011-2323-y (2012).","journal-title":"Rheumatol Int."},{"key":"1685_CR37","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1164\/ajrccm\/136.5.1285","volume":"136","author":"American Thoracic Society","year":"1987","unstructured":"American Thoracic Society. Standardization of spirometry-1987 up date. American Review of Respiratory Disease. \n                           136, 1285\u20131298, doi:10.1164\/ajrccm\/136.5.1285 (1987).","journal-title":"American Review of Respiratory Disease."},{"key":"1685_CR38","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1164\/ajrccm\/136.5.1299","volume":"136","author":"American Thoracic Society","year":"1987","unstructured":"American Thoracic Society. Single breath carbon monoxide diffusing capacity (transfer factor). Recommendations for a standard technique. Statement of the American Thoracic Society. American Review of Respiratory Disease. \n                           136, 1299\u20131307, doi:10.1164\/ajrccm\/136.5.1299 (1987).","journal-title":"American Review of Respiratory Disease."},{"key":"1685_CR39","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1164\/ajrccm\/144.5.1202","volume":"144","author":"American Thoracic Society","year":"1991","unstructured":"American Thoracic Society. Lung function testing: selection of reference values and interpretative strategies. American Review of Respiratory Disease. \n                           144, 1202\u20131218, doi:10.1164\/ajrccm\/144.5.1202 (1991).","journal-title":"American Review of Respiratory Disease."},{"key":"1685_CR40","doi-asserted-by":"publisher","first-page":"977","DOI":"10.2214\/ajr.169.4.9308447","volume":"169","author":"EA Kazerooni","year":"1997","unstructured":"Kazerooni, E. A. et al. Thin-section CT obtained at 10-mm increments versus limited three-level thin-section CT for idiopathic pulmonary fibrosis: correlation with pathologic scoring. AJR Am J Roentgenol. \n                           169, 977\u2013983, doi:10.2214\/ajr.169.4.9308447 (1997).","journal-title":"AJR Am J Roentgenol."},{"key":"1685_CR41","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1093\/rheumatology\/kes012","volume":"51","author":"T Gono","year":"2012","unstructured":"Gono, T. et al. Hyperferritinaemia and macrophage activation in a patient with interstitial lung disease with clinically amyopathic DM. Rheumatology (Oxford). \n                           51, 1336\u20131338, doi:10.1093\/rheumatology\/kes012 (2012).","journal-title":"Rheumatology (Oxford)."},{"key":"1685_CR42","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1007\/s00296-002-0243-6","volume":"23","author":"G Kum\u00e1novics","year":"2003","unstructured":"Kum\u00e1novics, G., Magyarlaki, T., Kom\u00f3csi, A., Szekeres, G. & Czirj\u00e1k, L. Simultaneous presence of neutrophil alveolitis and Ki-67 positivity of alveolar macrophages in dermato-\/polymyositis and systemic sclerosis. Rheumatol Int. \n                           23, 6\u201310, doi:10.1007\/s00296-002-0243-6 (2003).","journal-title":"Rheumatol Int."},{"key":"1685_CR43","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1046\/j.1365-2249.2002.01933.x","volume":"129","author":"K Kurasawa","year":"2002","unstructured":"Kurasawa, K. et al. Activation of pulmonary T cells in corticosteroid-resistant and -sensitive interstitial pneumonitis in dermatomyositis\/polymyositis. Clin Exp Immunol. \n                           129, 541\u2013548, doi:10.1046\/j.1365-2249.2002.01933.x (2002).","journal-title":"Clin Exp Immunol."},{"key":"1685_CR44","doi-asserted-by":"publisher","first-page":"409","DOI":"10.2174\/187153006779025775","volume":"6","author":"H Kameda","year":"2006","unstructured":"Kameda, H. & Takeuchi, T. Recent advances in the treatment of interstitial lung disease in patients with polymyositis\/dermatomyositis. Endocr Metab Immune Disord Drug Targets. \n                           6, 409\u2013415, doi:10.2174\/187153006779025775 (2006).","journal-title":"Endocr Metab Immune Disord Drug Targets."},{"key":"1685_CR45","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1172\/JCI4174","volume":"102","author":"RI Enelow","year":"1998","unstructured":"Enelow, R. I. et al. Structural and functional consequences of alveolar cell recognition by CD8(+) T lymphocytes in experimental lung disease. J Clin Invest. \n                           102, 1653\u20131661, doi:10.1172\/JCI4174 (1998).","journal-title":"J Clin Invest."},{"key":"1685_CR46","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1002\/art.24631","volume":"60","author":"TJ Richards","year":"2009","unstructured":"Richards, T. J. et al. Characterization and peripheral blood biomarker assessment of Jo-1 antibody-positive interstitial lung disease. Arthritis Rheum. \n                           60, 2183\u20132192, doi:10.1002\/art.v60:7 (2009).","journal-title":"Arthritis Rheum."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-01685-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-01685-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-01685-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T04:08:22Z","timestamp":1671768502000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-01685-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,9]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["1685"],"URL":"https:\/\/doi.org\/10.1038\/s41598-017-01685-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,9]]},"assertion":[{"value":"16 November 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"1635"}}